EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
Equillium, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.24+0.05 (+4.20%)
Close on Oct 19, 2026
- Market cap
- $138.64M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.22 (−15.07%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $138.64M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 2.47
- Dividend yield
- –
- Free cash flow yield
- -14.49%
Fundamentals
- Net income
- -$18.01M
- EPS, diluted
- -$0.39
- Free cash flow
- -$20.09M
- Book value per share
- $0.50
- Diluted shares
- 112M
Nine years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Revenue
–
Operating income
-$19.30M
Net income
-$18.01M
EPS, diluted
–
Free cash flow
-$20.09M
Reported periodTrailing twelve months